Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adverse events after coronary artery bypass grafting in patients with preoperative metabolic syndrome: A 10-year follow-up of the Veterans Affairs Database.
Deo SV, Sundaram V, Wilson B, Sahadevan J, Madan Mohan SK, Rubelowsky J, Elgudin Y, Cmolik B. Deo SV, et al. Among authors: elgudin y. J Thorac Cardiovasc Surg. 2022 Jun;163(6):2096-2103.e3. doi: 10.1016/j.jtcvs.2020.08.018. Epub 2020 Aug 12. J Thorac Cardiovasc Surg. 2022. PMID: 32919773 Free article.
Revascularization in ischaemic heart failure with preserved ejection fraction: a nationwide cohort study.
Deo SV, Reddy YNV, Zakeri R, Karnib M, Selvaganesan P, Elgudin Y, Kilic A, Rubelowsky J, Altarabsheh SE, Osman MN, Josephson RA, Mohan SKM, Cmolik B, Simon DI, Rajagopalan S, Cleland JGF, Sahadevan J, Sundaram V. Deo SV, et al. Among authors: elgudin y. Eur J Heart Fail. 2022 Aug;24(8):1427-1438. doi: 10.1002/ejhf.2446. Epub 2022 Mar 10. Eur J Heart Fail. 2022. PMID: 35119162 Free article.
Lipid Lowering in "Very High Risk" Patients Undergoing Coronary Artery Bypass Surgery and Its Projected Reduction in Risk for Recurrent Vascular Events: A Monte Carlo Stepwise Simulation Approach.
Deo S, Ueda P, Sheikh AM, Altarabsheh S, Elgudin Y, Rubelowsky J, Cmolik B, Hawkins N, McAllister D, Ruel M, Sattar N, Pell J. Deo S, et al. Among authors: elgudin y. J Cardiovasc Pharmacol. 2023 Feb 1;81(2):120-128. doi: 10.1097/FJC.0000000000001374. J Cardiovasc Pharmacol. 2023. PMID: 36315474 Free article.
49 results